Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Warner Music
WMG
$15.1B
| $38.9M | 0.06% |
1,521,800
+713,578
| +88% | +$20.2M |
2025 Q1
4 quarters
|
|
402
Manulife Financial
MFC
$69.7B
| $38.8M | 0.06% |
1,125,424
+737,100
| +190% | +$26.5M |
2024 Q4
5 quarters
|
|
|
SOLS
403
Solstice Advanced Materials
SOLS
$9.57B
| $38.4M | 0.06% |
+504,100
| New | +$34.6M |
2026 Q1
0 quarters
|
|
404
Acadia Pharmaceuticals
ACAD
$3.37B
| $38.4M | 0.06% |
1,724,196
+191,600
| +13% | +$4.58M |
2023 Q4
9 quarters
|
|
405
D.R. Horton
DHI
$38B
| $38.4M | 0.06% |
279,538
-384,000
| -58% | -$58M |
2025 Q4
1 quarter
|
|
406
TJX Companies
TJX
$153B
| $38.1M | 0.06% |
238,500
-317,800
| -57% | -$49.5M |
2023 Q4
9 quarters
|
|
407
Symbotic
SYM
$5.46B
| $38M | 0.06% |
714,800
-190,900
| -21% | -$10.9M |
2025 Q2
3 quarters
|
|
408
Ciena
CIEN
$60.4B
| $38M | 0.06% |
97,800
+65,200
| +200% | +$19.9M |
2025 Q4
1 quarter
|
|
409
Royalty Pharma
RPRX
$25B
| $37.9M | 0.06% |
+790,937
| New | +$34.6M |
2026 Q1
0 quarters
|
|
410
Cenovus Energy
CVE
$58.1B
| $37.9M | 0.06% |
1,427,294
-3,845,400
| -73% | -$82M |
2019 Q1
28 quarters
|
|
|
APLS
411
DELISTED
Apellis Pharmaceuticals
APLS
| $37.7M | 0.06% |
935,958
+302,900
| +48% | +$6.53M |
2025 Q2
3 quarters
|
|
412
Madrigal Pharmaceuticals
MDGL
$11B
| $37.6M | 0.06% |
71,870
-11,992
| -14% | -$5.73M |
2024 Q3
6 quarters
|
|
413
Viper Energy
VNOM
$8.29B
| $37.5M | 0.06% |
+797,278
| New | +$34.2M |
2026 Q1
0 quarters
|
|
414
Biogen
BIIB
$32.3B
| $37.3M | 0.06% |
203,396
-195,800
| -49% | -$36.1M |
2018 Q1
32 quarters
|
|
|
FISV
415
Fiserv Inc
FISV
$24.4B
| $37.3M | 0.06% |
668,227
+543,900
| +437% | +$33.7M |
2025 Q2
3 quarters
|
|
416
SoFi Technologies
SOFI
$20.2B
| $36.8M | 0.06% |
+2,317,400
| New | +$48.8M |
2026 Q1
0 quarters
|
|
417
Freshworks
FRSH
$3.56B
| $36.7M | 0.06% |
4,576,000
+2,021,412
| +79% | +$18.6M |
2021 Q4
17 quarters
|
|
418
Hudbay
HBM
$11.3B
| $36.7M | 0.06% |
1,755,509
-436,400
| -20% | -$10.2M |
2016 Q2
39 quarters
|
|
|
TGB
419
Trekor Metals
TGB
$3.04B
| $36.6M | 0.06% |
5,682,070
+267,640
| +5% | +$1.94M |
2013 Q2
51 quarters
|
|
420
Grand Canyon Education
LOPE
$4.18B
| $36.6M | 0.06% |
215,102
-95,600
| -31% | -$16M |
2020 Q1
24 quarters
|
|
421
Radware
RDWR
$1.24B
| $36.5M | 0.06% |
1,388,231
-237,795
| -15% | -$5.91M |
2014 Q3
46 quarters
|
|
|
SGI
422
Somnigroup International
SGI
$14.4B
| $36.5M | 0.06% |
494,100
+325,700
| +193% | +$28.3M |
2025 Q4
1 quarter
|
|
423
CRA International
CRAI
$1.11B
| $36.3M | 0.06% |
224,475
+10,500
| +5% | +$1.89M |
2014 Q1
48 quarters
|
|
424
PTC Therapeutics
PTCT
$5.22B
| $36.3M | 0.06% |
533,300
-74,289
| -12% | -$5.26M |
2023 Q3
10 quarters
|
|
425
LPL Financial
LPLA
$25.8B
| $36.3M | 0.06% |
120,540
+6,480
| +6% | +$2.17M |
2025 Q1
4 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.